CYP7A1 and Hepatic steatosis: Similarly, Guangqiang Wang et al. [15] engineered a high-activity BSH strain which attenuated hepatic steatosis by enhancing bile acid deconjugation, suppressing the FXR signaling, and upregulating cholesterol 7α-hydroxylase (CYP7A1) expression.